Catalyst Biosciences Inc (NASDAQ: CBIO) stock enjoyed a major increase of 10.9% on 12/20/23. The shares closed at $28.70. NORMAL trading volume accompanied the advance. The stock has risen 42.6% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
CBIO is expected to be a major Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Catalyst Biosciences is currently unrated.
Rating Review
The stock is currently unrated.